84 related articles for article (PubMed ID: 12890369)
21. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass.
Ceylan E; Kocyigit A; Gencer M; Aksoy N; Selek S
Respir Med; 2006 Jul; 100(7):1270-6. PubMed ID: 16307872
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphism of GSTT1 and GSTM1 and susceptibility to chronic obstructive pulmonary disease (COPD).
Faramawy MM; Mohammed TO; Hossaini AM; Kashem RA; Abu Rahma RM
J Crit Care; 2009 Sep; 24(3):e7-10. PubMed ID: 19664521
[TBL] [Abstract][Full Text] [Related]
23. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A
Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
[TBL] [Abstract][Full Text] [Related]
24. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD.
Stratelis G; Mölstad S; Jakobsson P; Zetterström O
Scand J Prim Health Care; 2006 Sep; 24(3):133-9. PubMed ID: 16923621
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
Stav D; Raz M
Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
[TBL] [Abstract][Full Text] [Related]
26. Intronic single-nucleotide polymorphisms in Bcl-2 are associated with chronic obstructive pulmonary disease severity.
Sata M; Takabatake N; Inoue S; Shibata Y; Abe S; Machiya J; Wada T; Ji G; Kido T; Matsuura T; Muramatsu MA; Kubota I
Respirology; 2007 Jan; 12(1):34-41. PubMed ID: 17207023
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
[TBL] [Abstract][Full Text] [Related]
28. Predicted versus observed FEV1 in the immediate postoperative period after pulmonary lobectomy.
Varela G; Brunelli A; Rocco G; Marasco R; Jiménez MF; Sciarra V; Aranda JL; Gatani T
Eur J Cardiothorac Surg; 2006 Oct; 30(4):644-8. PubMed ID: 16893655
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease.
Albers M; Schermer T; Heijdra Y; Molema J; Akkermans R; van Weel C
Thorax; 2008 Mar; 63(3):201-7. PubMed ID: 17905823
[TBL] [Abstract][Full Text] [Related]
30. Association between cytochrome P450 3A5 polymorphism and the lung function in Saskatchewan grain workers.
Seo T; Pahwa P; McDuffie HH; Yurube K; Egoshi M; Umemoto Y; Ghosh S; Fukushima Y; Nakagawa K
Pharmacogenet Genomics; 2008 Jun; 18(6):487-93. PubMed ID: 18496128
[TBL] [Abstract][Full Text] [Related]
31. [Occupational chronic obstructive pulmonary disease: Italian law (decree no. 336/1994) and epidemiological evidence].
Mastrangelo G; Fedeli U; Fadda E; Milan G; Saia B
Med Lav; 2004; 95(1):11-6. PubMed ID: 15112743
[TBL] [Abstract][Full Text] [Related]
32. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
[TBL] [Abstract][Full Text] [Related]
33. Impact on pulmonary function after lobectomy in patients with chronic obstructive pulmonary disease.
Schattenberg T; Muley T; Dienemann H; Pfannschmidt J
Thorac Cardiovasc Surg; 2007 Dec; 55(8):500-4. PubMed ID: 18027336
[TBL] [Abstract][Full Text] [Related]
34. The effect of smoking-related hyperhomocysteinemia on spirometric declines in chronic obstructive pulmonary disease in elderly Japanese.
Kai S; Nomura A; Morishima Y; Ishii Y; Sakamoto T; Hegab AE; Sekizawa K
Arch Gerontol Geriatr; 2006; 42(2):117-24. PubMed ID: 16125804
[TBL] [Abstract][Full Text] [Related]
35. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
[TBL] [Abstract][Full Text] [Related]
36. Reactive oxygen metabolites as an index of chronic obstructive pulmonary disease severity.
Markoulis N; Gourgoulianis KI; Moulas A; Gerogianni E; Molyvdas AP
Panminerva Med; 2006 Dec; 48(4):209-13. PubMed ID: 17215792
[TBL] [Abstract][Full Text] [Related]
37. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
[TBL] [Abstract][Full Text] [Related]
38. Influence of the site of lobectomy and chronic obstructive pulmonary disease on pulmonary function: a follow-up analysis.
Kushibe K; Kawaguchi T; Kimura M; Takahama M; Tojo T; Taniguchi S
Interact Cardiovasc Thorac Surg; 2009 May; 8(5):529-33. PubMed ID: 19201779
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of outpatients with COPD in daily practice: The E4 Spanish project.
Viejo-Bañuelos JL; Pueyo-Bastida A; Fueyo-Rodríguez A
Respir Med; 2006 Dec; 100(12):2137-43. PubMed ID: 16831541
[TBL] [Abstract][Full Text] [Related]
40. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
